ATE119888T1 - 5-(amino)-triazolylcarbothioamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel sowie verwendung der ersteren. - Google Patents

5-(amino)-triazolylcarbothioamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel sowie verwendung der ersteren.

Info

Publication number
ATE119888T1
ATE119888T1 AT90122351T AT90122351T ATE119888T1 AT E119888 T1 ATE119888 T1 AT E119888T1 AT 90122351 T AT90122351 T AT 90122351T AT 90122351 T AT90122351 T AT 90122351T AT E119888 T1 ATE119888 T1 AT E119888T1
Authority
AT
Austria
Prior art keywords
alkyl
group
bearing
formula
straight
Prior art date
Application number
AT90122351T
Other languages
German (de)
English (en)
Inventor
Jozsef Dr Barkoczy
Jozsef Dr Reiter
Laszlo Dr Pongo
Lujza Dr Petocz
Frigyes Dr Goergenyi
Marton Dr Fekete
Gabor Gigler
Istvan Gacsalyi
Istvan Gyertyan
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Application granted granted Critical
Publication of ATE119888T1 publication Critical patent/ATE119888T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
AT90122351T 1989-11-24 1990-11-23 5-(amino)-triazolylcarbothioamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel sowie verwendung der ersteren. ATE119888T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU896163A HU206096B (en) 1989-11-24 1989-11-24 Process for producing triazolylcarboxylic acid thioamide derivatives and pharmaceutical compositions comprising same

Publications (1)

Publication Number Publication Date
ATE119888T1 true ATE119888T1 (de) 1995-04-15

Family

ID=10971287

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90122351T ATE119888T1 (de) 1989-11-24 1990-11-23 5-(amino)-triazolylcarbothioamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel sowie verwendung der ersteren.

Country Status (22)

Country Link
US (2) US5175163A (enExample)
EP (1) EP0434982B1 (enExample)
JP (1) JPH03209371A (enExample)
KR (1) KR910009674A (enExample)
CN (1) CN1052116A (enExample)
AT (1) ATE119888T1 (enExample)
BG (1) BG60318B2 (enExample)
CA (1) CA2030775A1 (enExample)
CZ (1) CZ280559B6 (enExample)
DE (1) DE59008718D1 (enExample)
DK (1) DK0434982T3 (enExample)
ES (1) ES2029778T3 (enExample)
FI (1) FI905800A7 (enExample)
GR (1) GR910300109T1 (enExample)
HU (1) HU206096B (enExample)
IL (1) IL96452A0 (enExample)
IN (1) IN171500B (enExample)
PH (1) PH27376A (enExample)
PL (1) PL166887B1 (enExample)
RU (1) RU2045521C1 (enExample)
TW (1) TW210335B (enExample)
ZA (1) ZA909409B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750545A (en) * 1993-07-23 1998-05-12 The Green Cross Corporation Triazole derivative and pharmaceutical use thereof
EP1355889B1 (en) * 2000-12-22 2006-06-07 Ortho-McNeil Pharmaceutical, Inc. Substituted triazole diamine derivatives as kinase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2352944A (en) * 1942-07-04 1944-07-04 Gen Electric Triazole derivatives
GB949170A (en) * 1960-03-15 1964-02-12 France Etat Carbamyl and thiocarbamyl substances, methods for producing same and applications thereof
US4421753A (en) * 1982-01-15 1983-12-20 American Cyanamid Company 1-(5-Amino-4H-1,2,4-triazol-3-yl)-4-substituted-piperazines
DD205905A1 (de) * 1982-08-17 1984-01-11 Univ Rostock Verfahren zur herstellung von substituierten 1,2,4-triazolo (2,3-a)-1,3,5-triazinen

Also Published As

Publication number Publication date
PL287909A1 (en) 1991-09-23
FI905800A0 (fi) 1990-11-23
ES2029778T3 (es) 1995-06-01
ZA909409B (en) 1991-09-25
CN1052116A (zh) 1991-06-12
TW210335B (enExample) 1993-08-01
RU2045521C1 (ru) 1995-10-10
CZ583990A3 (en) 1995-11-15
US5276030A (en) 1994-01-04
EP0434982B1 (de) 1995-03-15
CA2030775A1 (en) 1991-05-25
CZ280559B6 (cs) 1996-02-14
JPH03209371A (ja) 1991-09-12
IL96452A0 (en) 1991-08-16
HUT59112A (en) 1992-04-28
GR910300109T1 (en) 1991-12-10
US5175163A (en) 1992-12-29
DE59008718D1 (de) 1995-04-20
DK0434982T3 (da) 1995-05-22
EP0434982A3 (en) 1991-12-18
ES2029778T1 (es) 1992-10-01
PH27376A (en) 1993-06-21
PL166887B1 (pl) 1995-06-30
BG60318B2 (bg) 1994-07-25
EP0434982A2 (de) 1991-07-03
HU206096B (en) 1992-08-28
HU896163D0 (en) 1990-02-28
FI905800A7 (fi) 1991-05-25
IN171500B (enExample) 1992-10-31
KR910009674A (ko) 1991-06-28

Similar Documents

Publication Publication Date Title
ATE174590T1 (de) 4-aminopyridine, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
ATE185807T1 (de) Thiazolylbenzofuranderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die sie enthalten
ATE286032T1 (de) Heterozyklische verbindungen,und deren verwendung in arzneimittel,verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ATE210134T1 (de) Heterocyclisch substituierte imidazolidine, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zubereitungen
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69308029D1 (de) 1,2,3,5,6,7,8,8a-OCTAHYDRO-5,5,8a-TRIMETHYL-(8aBETA)-6-ISOCHINOLINAMINE-DERIVATE, IHRE HERSTELLUNG UND VERWENDUNG ALS THERAPEUTIKA
DE3777852D1 (de) Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
ATE127807T1 (de) N-heteroaryl-purin-6-amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
AU8824391A (en) New guanidine compounds, process for preparing these and pharmaceutical compositions containing them
ATE124408T1 (de) Heterozyklische aminderivate, deren herstellung und deren verwendung.
ES8203354A1 (es) Un procedimiento para la produccion de nuevos derivados heterociclicos,.
KR890014502A (ko) 대뇌-활성 약물 및 중추근이완제로서 사용하기 위한 신규 이소옥사졸 유도체류
ATE119888T1 (de) 5-(amino)-triazolylcarbothioamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel sowie verwendung der ersteren.
FI920425A0 (fi) Cykloalkylenazoler, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska preparat och deras anvaendning vid framstaellning av laekemedel.
ATE91489T1 (de) Heterocyclische propenamid-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3480839D1 (de) Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung.
DE60202969D1 (de) Substituierte alkylaminopyridazinonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE69409734D1 (de) Neue Derivate des 2-(1H)-Chinolinones, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
ES8201977A1 (es) Procedimiento de preparacion de aminoalcoxipirazoles
ATE123493T1 (de) 3-(1h-indazol-3-yl)-4-pyridiname, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel.
AU4301189A (en) New thienyloxy-alkylamine derivates, their process of production and medicaments containing these compounds
GEP20002212B (en) Clavulanic Acid and Diamino Ether Derivatives, Di-Clavulanate Salt, Method for Its Production and Pharmaceutical Composition on Its Basis
ATE168371T1 (de) 5-amino-5,6,7,8-tetrahydrochinoline und verwandte verbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE23150T1 (de) Aminoethoxybenzylalkohol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE138068T1 (de) 1,2,4-triazolo(1,5-a>pyrimidinderivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung